The Journal of Experimental Medicine
Avanti Polar Lipids, Inc.
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Email this article
Right arrow Alert me to new content in the JEM
Citing Articles
Right arrow Citing Articles via CrossRef

Index of Online Supplemental Material for
J. Exp. Med. 10.1084/jem.20070285
Wu et al.

Figure S1 The signal strength of various CpG-ODNs.

Figure S2 Isolated subpopulation of DCs based on CD8α staining.

Figure S3 Intracellular IL-12 staining in WT and TLR9 KO DC after CpG stimulation.

Figure S4 Loss of NK cells in IL-15-deficient and anti-asialo-GM1-treated mice.

Figure S5 Cells of the adaptive immune system are not needed for CpG-mediated arthritis inhibition.

Figure S6 IL-2 is not the “priming” cytokine.

Figure S7 Inhibition of IDO does not have an impact on CpG-mediated protection.

Figure S8 The population of NK, DC, and IKDC in spleen after CpG stimulation.

Figure S9 Depletion of pDCs results in partial protection of CpG.

Supplemental text (PDF)





This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Email this article
Right arrow Alert me to new content in the JEM
Citing Articles
Right arrow Citing Articles via CrossRef


  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS